Showing results (2631-2640 of 9,335) with videos related to
Sort By:
Pageof 934
Cancer Medicine|August 18, 2021
Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective studyTressie Herrmann, Angeline Ginzac, Ioana Molnar, et al.Cancer Medicine|May 6, 2020
The neonatal Fc receptor in cancer FcRn in cancerDiana Cadena Castaneda, Guillaume Brachet, Caroline Goupille, et al.Cancer Medicine|May 15, 2015
Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast CancerColin B Begg, Irene Orlow, Emily C Zabor, et al.Cancer Medicine|July 22, 2016
peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomasElena Martínez-Sáez, Vicente Peg, Arantxa Ortega-Aznar, et al.Cancer Medicine|July 20, 2016
The impact of complete surgical resection of spinal metastases on the survival of patients with thyroid cancerSatoshi Kato, Hideki Murakami, Satoru Demura, et al.Cancer Medicine|August 26, 2025
GATA3 as a Prognostic Marker in Early-Stage Classical Mycosis Fungoides: Association With Disease Progression and Survival OutcomesPengfei Wen, Fan Li, Yao Xie, et al.Cancer Medicine|April 23, 2020
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Odoardo Olimpieri, et al.Cancer Medicine|April 23, 2020
Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trialPasquale F Innominato, Annabelle Ballesta, Qi Huang, et al.Cancer Medicine|June 20, 2020
Cardiovascular disease and asymptomatic childhood cancer survivors: Current clinical practiceWendy J Bottinor, Debra L Friedman, Thomas D Ryan, et al.Cancer Medicine|June 21, 2020
AST/ALT ratio as a significant predictor of the incidence risk of prostate cancerJiatong Zhou, Zhaowei He, Shenfei Ma, et al.Pageof 934